Systematic Critical Review of Economic Evaluations of Rituximab, Added to Conventional Chemotherapy Regimen in the Treatment of Patients with Chronic Lymphocytic Leukemic Refractory
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.2283
https://www.valueinhealthjournal.com/article/S1098-3015(14)04213-2/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1741
First Page :
A636
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04213-2&doi=10.1016/j.jval.2014.08.2283